3rd Circ. Sends J&J Remicade Antitrust Fight to Arbitration
The Third Circuit ruled on Friday that antitrust claims from Rochester Drug Cooperative Inc. over allegedly inflated prices it paid for the Johnson & Johnson immunosuppressant Remicade fell within the scope...To view the full article, register now.
Already a subscriber? Click here to view full article